Lakefront Biotherapeutics NV (AMS:LKFT)
23.84
-0.16 (-0.67%)
At close: May 26, 2026
AMS:LKFT Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, AMS:LKFT stock has a consensus rating of "Hold" and an average price target of €30.15. The average 1-year stock price forecast is 26.47% higher than the current stock price, while the lowest is €19.00 (-20.30%) and the highest is €44.80 (+87.92%).
Price Target: €30.15 (+26.47%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for AMS:LKFT stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 2 | 2 | 2 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 2 | 2 | 2 | 2 |
| Total | 9 | 9 | 10 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell Maintains €22.00 | Sell | Maintains | €22.00 | -7.72% | May 7, 2026 |
| Kepler Capital | Kepler Capital | Sell Maintains €23.50 | Sell | Maintains | €23.50 | -1.43% | May 7, 2026 |
| UBS | UBS | Hold Maintains €30.00 | Hold | Maintains | €30.00 | +25.84% | Apr 1, 2026 |
| Bernstein | Bernstein | Hold Maintains €27.90 | Hold | Maintains | €27.90 | +17.03% | Mar 31, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.